LONDON-- Pharmaceutical services group Ergomed PLC (ERGO.LN) Thursday announced the appointment of Andrew Mackie, who has held senior research and development roles at pharma companies including Novartis AG (NVS) and Sanofi (SNY), as Chief Business Officer and executive director, effective from 1 July 2015.

Shares at 0717 GMT, unchanged at 180 pence valuing the company at GBP51.6 million.

-Write to Rory Gallivan at rory.gallivan@wsj.com; Twitter: @RoryGallivan

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Novartis (NYSE:NVS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Novartis Charts.
Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Novartis Charts.